Editorial illustration for Musk says he was duped, warns AI could kill us, xAI to IPO via SpaceX in June
Musk says he was duped, warns AI could kill us, xAI to...
Musk says he was duped, warns AI could kill us, xAI to IPO via SpaceX in June
Why does this matter now? Musk has spent the week railing against Sam Altman, insisting he was “duped” by the OpenAI chief and warning that “AI could kill us all.” While the rhetoric dominates headlines, another, less flashy development is taking shape behind the scenes. The same Elon Musk who rockets rockets is also positioning his nascent AI venture, xAI, for a public debut.
He’s not treating the startup like a stand‑alone tech play; instead, he plans to bundle it with SpaceX, the aerospace firm that already commands a multitrillion‑dollar market cap. That move signals a strategic gamble: tie an AI lab to a proven launch platform and let the two feed each other’s credibility. It also raises the stakes for investors, who will have to weigh a moon‑shot valuation against the very real concerns Musk voiced about unchecked artificial intelligence.
In short, the upcoming listing could reshape how capital flows to AI, especially when the founder is simultaneously sounding the alarm and cashing in.
He said that when he asked Google cofounder Larry Page what happens if AI tries to wipe out humanity, Page told him, “That will be fine as long as artificial intelligence survives.
The courtroom was quiet as Musk took the stand. He said Altman and Brockman had misled him into funding OpenAI, a claim that has yet to be verified by the other side. He warned that unchecked AI could destroy humanity, a stark reminder of the stakes many investors cite. At the same time, he admitted to poaching OpenAI staff for his own ventures, and even acknowledged that xAI “distills” OpenAI’s models—a detail that raises questions about intellectual‑property boundaries.
Concurrently, xAI is slated to go public through SpaceX as early as June, with a headline‑grabbing target valuation of $1.75 trillion. Whether the merger will survive regulatory scrutiny, or how the market will price a company built on borrowed technology, remains uncertain. Will the IPO shift the balance of power in the AI sector, or simply add another high‑profile entry? The trial continues, and the answers will likely shape both legal outcomes and the broader conversation about AI’s societal impact.
Further Reading
- SpaceX warns about this xAI 'problem' before IPO; risk filing says Grok's content may lead company to lose access to - Times of India
- 'I literally was a fool': Musk grilled in OpenAI trial - ABS-CBN
- Elon Musk's SpaceX Warns Of Market Bans As xAI Faces ... - Benzinga
- SpaceX Warns Probes Into xAI Could Limit Market Access - MIT Sloan Middle East
Related Reading
Research & Benchmarks DeepMind spinoff’s AI‑designed drugs enter human trials after AlphaFold 3
Research & Benchmarks Hyperparameter Tuning Reaches 0.9617 Accuracy in 64.59 Seconds
Research & Benchmarks Google AI Advisors Let Users Probe Performance with Conversational “Why” Queries
Related Topic Anthropic's Claude also citing Elon Musk's Grokipedia, reports say
LLMs & Generative AI
Related Topic Grok AI creates one nonconsensual sexualized image per minute, minors included
AI Tools & Apps
From Archives Google DeepMind AI co‑clinician beats GPT‑5.4 in blind tests, lags docs
From Archives Anthropic benchmark says Claude matches experts, 23 tasks remain ambiguous
From Archives Musk loses bid to hide xAI safety record, credibility questioned on OpenAI stand
Policy & Regulation
From Archives xAI releases Grok 4.3 with low price and fast voice‑cloning suite
Business & Startups